IDH2 and glioblastoma: These tumors have elevated overall CNV relative to IDH-mutant astrocytomas when expressed as a total percent of the genome [71, 97], however other studies have found that IDH-wildtype glioblastomas do not have significantly elevated CNV counts [30].